Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression

被引：0
|
作者：
Michelle Junyi He
Wenjun Pu
Xi Wang
Xiaoni Zhong
Dong Zhao
Zhipeng Zeng
Wanxia Cai
Jiayi Liu
Jianrong Huang
Donge Tang
Yong Dai
机构：
[1] The Second Clinical Medical College of Jinan University,Clinical Medical Research Center
[2] Shenzhen People’s Hospital,Department of Biology, Department of Brain and Cognitive Sciences
[3] Massachusetts Institute of Technology,The First Affiliated Hospital
[4] Jinan University,The First Affiliated Hospital (Shenzhen People’s Hospital)
[5] Southern University of Science and Technology,Department of Nephrology Center, Department of Liver Transplant Center, The Third People’s Hospital of Shenzhen
[6] The Second Affiliated Hospital of Southern University of Science and Technology,Guangxi Key Laboratory of Metabolic Disease Research
[7] Central Laboratory of Guilin,undefined
[8] 924St Hospital,undefined
来源：
Cancer Cell International | / 22卷
关键词：
Spatial metabolomics; Liver cirrhosis; Hepatocellular carcinoma; Disease progression; Amino acid metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The liver enzymes in patients with cirrhosis and hepatocellular carcinoma (HCC)
    Serdarevic, N.
    Frankovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S155 - S155
  • [32] Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
    Danila, Mirela
    Sirli, Roxana
    Tudora, Adriana
    Popescu, Alina
    Sporea, Ioan
    Guta, Adina
    GASTROENTEROLOGY, 2010, 138 (05) : S222 - S222
  • [33] Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?
    Colella, G
    DeCarlis, L
    Rondinara, GF
    Sansalone, CV
    Belli, LS
    Aseni, P
    Slim, AI
    Gelosa, F
    Iamoni, GM
    Corti, A
    Mazza, E
    Arcieri, K
    Giacomoni, A
    Minola, E
    Ideo, G
    Forti, D
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 492 - 494
  • [34] Laparoscopic liver resection for hepatocellular carcinoma in patients with cirrhosis
    Cheung, Tan
    Lo, Chung
    HEPATOBILIARY SURGERY AND NUTRITION, 2015, 4 (06) : 406 - 410
  • [35] PHARMACOKINETICS OF SUNITINIB IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
    Marco, Biolato
    Michele, Basso
    Elena, Strocchi
    Alessia, Amoruso
    Luca, Miele
    Marco, Campitiello
    Maurizio, Pompili
    Antonio, Grieco
    Carlo, Barone
    ANNALS OF ONCOLOGY, 2014, 25 : 24 - 24
  • [36] Safety of imatinib in patients with liver cirrhosis and hepatocellular carcinoma
    Ramadori, G
    Schleyer, E
    Armbrust, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 374S - 374S
  • [37] The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
    Shen, Jiliang
    Huang, Chiung-Kuei
    Yu, Hong
    Shen, Bo
    Zhang, Yaping
    Liang, Yuelong
    Li, Zheyong
    Feng, Xu
    Zhao, Jie
    Duan, Lian
    Cai, Xiujun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (05) : 986 - 992
  • [38] Sex hormones in patients with liver cirrhosis and hepatocellular carcinoma
    Montalto, G
    Miceli, MD
    Soresi, M
    Amodio, R
    Carroccio, A
    Cartabellotta, A
    Castagnetta, L
    ONCOLOGY REPORTS, 1997, 4 (01) : 173 - 176
  • [39] Development of hepatocellular carcinoma in liver cirrhosis: Pathomorphologic viewpoint
    Kojiro, M
    LIVER CIRRHOSIS, 2001, : 80 - 86
  • [40] RESULTS OF LIVER RESECTION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS
    SMADJA, C
    BERTHOUX, L
    KAHWAJI, F
    KEMENY, F
    GRANGE, D
    FRANCO, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1988, 12 (02): : 93 - 98
12345